Hester to produce and commercialize Classical Swine Fever Vaccine and Sheep Pox Vaccine

1. Classical Swine Fever Vaccine
2.
Sheep Pox Vaccine
These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for the country's requirement of Classical Swine Fever Vaccine and Sheep Pox Vaccine.
The agreements were signed on 26 March 2021, followed with a virtual ceremony that took place on 7 April 2021. The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.
Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection.

Related Keywords

India ,Hester Biosciences ,Department Of Agricultural ,Indian Council Of Agricultural Research ,Research Education ,Ministry Of Agriculture ,Indian Veterinary Research Institute ,Indian Council ,Agricultural Research ,Veterinary Research Institute ,Swine Fever Vaccine ,Mpox Vaccine ,Classical Swine Fever Vaccine ,Sheep Pox ,Agrinnovate India ,Capital Market ,இந்தியா ,ஹெஸ்டர் உயிர் அறிவியல் ,ஆராய்ச்சி கல்வி ,இந்தியன் கால்நடை ஆராய்ச்சி நிறுவனம் ,இந்தியன் சபை ,கால்நடை ஆராய்ச்சி நிறுவனம் ,பன்றி காய்ச்சல் தடுப்பூசி ,பாக்ஸ் தடுப்பூசி ,பாரம்பரிய பன்றி காய்ச்சல் தடுப்பூசி ,ஆடுகள் பாக்ஸ் ,மூலதனம் சந்தை ,